Report Forecasts the Cancer Immunotherapy Market Hitting $311.4B by 2031
A recently published report by Mordor Intelligence analyzes future projections, growth drivers and the key trends that are shaping the rapidly growing market for cancer immunotherapy. The report puts the valuation of this market in 2025 at $144.8 billion and projects that it will expand to $311.4 billion by 2031. This expected expansion shows the extent to which patients and clinicians are increasingly accepting immunotherapy as a major approach in cancer care. As a result, these treatments are shifting from being niche therapies and are becoming recognized treatment options by the mainstream medical community and the patients they serve. The…
